Health, Education, Labor, and Pensions Committee
- Referred To
Introduced: Jul 17, 2025
Latest action date: Jul 17, 2025
Current stage
In committee
The most advanced recorded stage is committee consideration.
Introduced
Jul 17, 2025
Latest action
Jul 17, 2025
Recorded roll calls
0
Civixly topics
Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.
Official CRS policy area
Health
Halting the Epidemic of Addiction and Loss Act of 2025
This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration.
Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.
Committees and subcommittees that received, reviewed, marked up, or reported this legislation.
Proposed changes to this measure, with their latest official outcome or action from Congress.gov.
No amendments are listed for this measure.
Checked against Congress.gov Sep 12, 2026.
Newest action first. Action language comes from the official Congress.gov record.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Recorded House and Senate votes connected to this bill. Your representatives appear first when available.
No connected roll-call votes are currently available for this bill.
0 comments
Loading comments...